Synthesis and evaluation of two novel 2-nitroimidazole derivatives as potential PET radioligands for tumor imaging
Authors:
- 1 May 2011
- journal article
- research article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 38 (4) , 501-508
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Pre-clinical evaluation of a 3-nitro-1,2,4-triazole analogue of [18F]FMISO as hypoxia-selective tracer for PETNuclear Medicine and Biology, 2010
- PET imaging of hypoxia using [18F]HX4: a phase I trialEuropean Journal of Nuclear Medicine and Molecular Imaging, 2010
- Preparation and evaluation of ethyl [18F]fluoroacetate as a proradiotracer of [18F]fluoroacetate for the measurement of glial metabolism by PETNuclear Medicine and Biology, 2009
- Molecular Imaging of HypoxiaJournal of Nuclear Medicine, 2008
- The Hypoxic Tumour Microenvironment, Patient Selection and Hypoxia-modifying TreatmentsClinical Oncology, 2007
- [18F]Fluoroazomycinarabinofuranoside (18FAZA) and [18F]Fluoromisonidazole (18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumorsNuclear Medicine and Biology, 2003
- Imaging hypoxia in tumorsSeminars in Nuclear Medicine, 2001
- Imaging of hypoxia in human tumors with [F-18]fluoromisonidazoleInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1992
- Radiolabeled fluoromisonidazole as an imaging agent for tumor hypoxiaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1989
- The Concentration of Oxygen Dissolved in Tissues at the Time of Irradiation as a Factor in RadiotherapyBritish Journal of Radiology, 1953